-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Moleculin Biotech, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2024.
- Moleculin Biotech, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $40K, a 66.7% increase year-over-year.
- Moleculin Biotech, Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $146K, a 8.96% increase year-over-year.
- Moleculin Biotech, Inc. annual Operating Lease, Payments for 2024 was $146K, a 8.96% increase from 2023.
- Moleculin Biotech, Inc. annual Operating Lease, Payments for 2023 was $134K, a 3.88% increase from 2022.
- Moleculin Biotech, Inc. annual Operating Lease, Payments for 2022 was $129K, a 6.52% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)